The debate over the use of Embryonic stem cells and the questionable
effectiveness of adult stem cells have led many scientists and
clinicians to concentrate their energies on umbilical-cord-derived stem
cells from healthy newborn babies. Amassing a very respectable track
record in terms of safety and clinical utility, cord-blood stem cells
can treat many diseases such as multiple sclerosis, amyotrophic lateral
sclerosis, stroke, diabetes, heart disease and certain degenerative eye
disorders.